Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eco-friendly chitosan-based nanostructures in diabetes mellitus therapy: Promising bioplatforms with versatile therapeutic perspectives.
Taheriazam A, Entezari M, Firouz ZM, Hajimazdarany S, Hossein Heydargoy M, Amin Moghadassi AH, Moghadaci A, Sadrani A, Motahhary M, Harif Nashtifani A, Zabolian A, Tabari T, Hashemi M, Raesi R, Jiang M, Zhang X, Salimimoghadam S, Ertas YN, Sun D. Taheriazam A, et al. Among authors: zabolian a. Environ Res. 2023 Jul 1;228:115912. doi: 10.1016/j.envres.2023.115912. Epub 2023 Apr 15. Environ Res. 2023. PMID: 37068723 Review.
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation.
Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, Ertas YN, Mirzaei S, Samarghandian S. Entezari M, et al. Among authors: zabolian a. Biomed Pharmacother. 2022 Feb;146:112563. doi: 10.1016/j.biopha.2021.112563. Epub 2021 Dec 29. Biomed Pharmacother. 2022. PMID: 35062059 Free article. Review.
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Paskeh MDA, et al. Among authors: zabolian a. Pharmacol Res. 2023 Jan;187:106553. doi: 10.1016/j.phrs.2022.106553. Epub 2022 Nov 15. Pharmacol Res. 2023. PMID: 36400343 Free article. Review.
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. Paskeh MDA, et al. Among authors: zabolian a. Biomed Pharmacother. 2022 Feb;146:112532. doi: 10.1016/j.biopha.2021.112532. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906772 Free article. Review.
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M, Ghanbarirad M, Taheriazam A, Sadrkhanloo M, Zabolian A, Goharrizi MASB, Hushmandi K, Aref AR, Ashrafizadeh M, Zarrabi A, Nabavi N, Rabiee N, Hashemi M, Samarghandian S. Entezari M, et al. Among authors: zabolian a. Biomed Pharmacother. 2022 Jun;150:112963. doi: 10.1016/j.biopha.2022.112963. Epub 2022 Apr 22. Biomed Pharmacother. 2022. PMID: 35468579 Free article. Review.
Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence.
Paskeh MDA, Mirzaei S, Orouei S, Zabolian A, Saleki H, Azami N, Hushmandi K, Baradaran B, Hashmi M, Aref AR, Ertas YN, Zarrabi A, Ashrafizadeh M, Samarghandian S. Paskeh MDA, et al. Among authors: zabolian a. Int J Biol Macromol. 2021 Nov 30;191:727-737. doi: 10.1016/j.ijbiomac.2021.09.089. Epub 2021 Sep 22. Int J Biol Macromol. 2021. PMID: 34562537 Review.
Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review.
Ashrafizadeh M, Samarghandian S, Hushmandi K, Zabolian A, Shahinozzaman M, Saleki H, Esmaeili H, Raei M, Entezari M, Zarrabi A, Najafi M. Ashrafizadeh M, et al. Among authors: zabolian a. Curr Mol Pharmacol. 2021 Oct 25;14(4):537-558. doi: 10.2174/1874467213666201217122544. Curr Mol Pharmacol. 2021. PMID: 33334302 Review.
62 results